Search

Your search keyword '"Quantitative Structure-Activity Relationship"' showing total 29,527 results

Search Constraints

Start Over You searched for: Descriptor "Quantitative Structure-Activity Relationship" Remove constraint Descriptor: "Quantitative Structure-Activity Relationship" Topic quantitative structure-activity relationship Remove constraint Topic: quantitative structure-activity relationship
29,527 results on '"Quantitative Structure-Activity Relationship"'

Search Results

1. Reduced estrogenic risks of a sunscreen additive: Theoretical design and evaluation of functionally improved salicylates.

2. Machine learning-based QSAR and LB-PaCS-MD guided design of SARS-CoV-2 main protease inhibitors.

3. Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA.

4. How safe are wild-caught salmons exposed to various industrial chemicals? First ever in silico models for salmon toxicity data gaps filling.

5. Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies.

6. The application of chemical similarity measures in an unconventional modeling framework c-RASAR along with dimensionality reduction techniques to a representative hepatotoxicity dataset.

7. From molecular descriptors to the developmental toxicity prediction of pesticides/veterinary drugs/bio-pesticides against zebrafish embryo: Dual computational toxicological approaches for prioritization.

8. In silico degradation of fluoroquinolones by a microalgae-based constructed wetland system.

9. Synthesis of thiazolidine-2,4-dione tethered 1,2,3-triazoles as α-amylase inhibitors: In vitro approach coupled with QSAR, molecular docking, molecular dynamics and ADMET studies.

10. Photochemical transformation of liquid crystal monomers in simulated environmental media: Kinetics, mechanism, toxicity variation and QSAR modeling.

11. New combined Inverse-QSAR and molecular docking method for scaffold-based drug discovery.

12. Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-Pyrazol amide derivatives: A multi-scale in silico modelling approach.

13. In silico screening-based discovery of benzamide derivatives as inhibitors of Rho-associated kinase-1 (ROCK1).

14. Does the accounting of the local symmetry fragments in quasi-SMILES improve the predictive potential of the QSAR models of toxicity toward tadpoles?

15. Synthesis, biological evaluation, theoretical calculations, QSAR and molecular docking studies of novel arylaminonaphthols as potent antioxidants and BChE inhibitors.

16. Molecular modeling strategy for detailing the primary mechanism of action of copanlisib to PI3K: combined ligand-based and target-based approach.

17. Prediction of chronic toxicity of pharmaceuticals in Daphnia magna by combining ortholog prediction, pharmacological effects, and quantitative structure-activity relationship.

18. Employing comparative QSAR techniques for the recognition of dibenzofuran and dibenzothiophene derivatives toward MMP-12 inhibition.

19. A QSAR study for predicting malformation in zebrafish embryo.

20. High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods.

21. In silico exploration of promising heterocyclic molecules against both acetylcholinesterase and butyrylcholinesterase enzymes.

22. Computational prediction of retention times of veterinary antibiotics obtained by liquid chromatography-mass spectrometry.

23. Data-Driven Modelling of Substituted Pyrimidine and Uracil-Based Derivatives Validated with Newly Synthesized and Antiproliferative Evaluated Compounds.

24. High-Throughput Screening and Prediction of Nucleophilicity of Amines Using Machine Learning and DFT Calculations.

25. Identification of Marine-Derived SLC7A11 Inhibitors: Molecular Docking, Structure-Based Virtual Screening, Cytotoxicity Prediction, and Molecular Dynamics Simulation.

26. Chemical Predictive Modelling and Natural Product-based Divergent Synthesis - Design of Type B PPAPs with Nanomolar Activities against MRSA.

27. Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation.

28. Discovery of Novel Acethydrazide-Containing Flavonol Derivatives as Potential Antifungal Agents.

29. Assessment of performance of the profilers provided in the OECD QSAR toolbox for category formation of chemicals.

30. Mathematical modeling for prediction of physicochemical characteristics of cardiovascular drugs via modified reverse degree topological indices.

31. Development of QSARs for cysteine-containing di- and tripeptides with antioxidant activity:influence of the cysteine position.

32. Robustaflavone as a novel scaffold for inhibitors of native and auto-proteolysed human neutrophil elastase.

33. Predicting repurposed drugs targeting the NS3 protease of dengue virus using machine learning-based QSAR, molecular docking, and molecular dynamics simulations.

34. Quantitative structure-insecticidal activity of essential oils on the human head louse ( Pediculus humanus capitis ).

35. Quantitative structure-activity relationship predicting toxicity of pesticides towards Daphnia magna.

36. Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models.

37. Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis.

38. In Silico Design and In Vitro Assessment of Bicyclic Trifluoromethylated Pyrroles as New Antibacterial and Antifungal Agents.

39. Multi-combined QSAR, molecular docking, molecular dynamics simulation, and ADMET of Flavonoid derivatives as potent cholinesterase inhibitors.

40. Exploring the potential of FDA approved anti-diabetic drugs for repurposing against COVID-19: a core combination of multiple computational strategies and integrated artificial intelligence.

41. The database makes the poison: How the selection of datasets in QSAR models impacts toxicant prediction of higher tier endpoints.

42. QSPR study of viscoplastic properties of peptide-based hydrogels.

43. Flavonoid as a Potent Antioxidant: Quantitative Structure-Activity Relationship Analysis, Mechanism Study, and Molecular Design by Synergizing Molecular Simulation and Machine Learning.

44. Safer and greener chemicals for the aquatic ecosystem: Chemometric modeling of the prolonged and chronic aquatic toxicity of chemicals on Oryzias latipes.

45. The novel angiotensin-I-converting enzyme inhibitory peptides from Scomber japonicus muscle protein hydrolysates: QSAR-based screening, molecular docking, kinetic and stability studies.

46. QSARtuna: An Automated QSAR Modeling Platform for Molecular Property Prediction in Drug Design.

47. Three-Dimensional Quantitative Structure-Activity Relationship Study of Transient Receptor Potential Vanilloid 1 Channel Antagonists Reveals Potential for Drug Design Purposes.

48. QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy.

49. In-silico mechanistic analysis of adsorption of Iodinated Contrast Media agents on graphene surface.

50. Multi-Target In-Silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors.

Catalog

Books, media, physical & digital resources